Position in LQDA
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$65,074,589
+$48,515,523 QoQ
Shares Held
816,187
+86.0% QoQ
Ownership
0.912%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#17
of 333 holders
Holding Since
Jun 2020
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LQDA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026FEDERATED HERMES, INC. holds $277,187,959 across 31 Drug Manufacturers - Specialty & Generic names. LQDA ranks #1 (23.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LQDA |
Liquidia Corp
This page
|
816,187 | $65,074,589 | |
| 2 | INDV |
Indivior Pharmaceuticals, Inc.
|
1,468,749 | $60,262,769 | |
| 3 | ELAN |
Elanco Animal Health Inc
|
1,543,944 | $37,996,460 | |
| 4 | IRWD |
Ironwood Pharmaceuticals Inc
|
3,231,238 | $13,603,511 | |
| 5 | AQST |
Aquestive Therapeutics, Inc.
|
3,112,561 | $12,948,253 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
76,569 | $12,904,938 | |
| 7 | ALKS |
Alkermes plc.
|
221,589 | $11,611,263 | |
| 8 | XERS |
Xeris Biopharma Holdings, Inc.
|
1,434,433 | $11,360,709 |
All Filings in LQDA
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $65,074,589 | 816,187 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $16,559,066 | 438,767 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $16,773,624 | 486,333 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $7,290,375 | 320,597 | Shares | Defined | 2025-11-03 | |
| 2024-03-31 | $2,383,850 | 161,617 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $21,124 | 3,332 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $557 | 71 | Shares | Defined | 2023-08-14 | |
| 2020-06-30 | $219,475 | 26,066 | Shares | Defined | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||